Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 145,609
  • Shares Outstanding, K 66,793
  • Annual Sales, $ 5,900 K
  • Annual Income, $ -126,610 K
  • EBIT $ -157 M
  • EBITDA $ -152 M
  • 60-Month Beta 2.82
  • Price/Sales 25.57
  • Price/Cash Flow N/A
  • Price/Book 1.45

Options Overview Details

View History
  • Implied Volatility 239.52% ( +57.34%)
  • Historical Volatility 72.31%
  • IV Percentile 83%
  • IV Rank 44.13%
  • IV High 502.13% on 09/20/24
  • IV Low 32.13% on 07/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 1.67
  • Today's Open Interest 24
  • Open Int (30-Day) 69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.32
  • Number of Estimates 4
  • High Estimate -0.25
  • Low Estimate -0.38
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +39.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.02 +2.48%
on 11/12/24
2.57 -19.46%
on 11/07/24
-0.32 (-13.39%)
since 10/11/24
3-Month
2.02 +2.48%
on 11/12/24
2.94 -29.59%
on 08/29/24
-0.28 (-11.91%)
since 08/12/24
52-Week
1.06 +95.28%
on 11/16/23
4.65 -55.48%
on 04/01/24
+0.92 (+80.00%)
since 11/10/23

Most Recent Stories

More News
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

GBIO : 2.09 (-4.13%)
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

GBIO : 2.09 (-4.13%)
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings

December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
SEDG : 12.22 (-10.67%)
AXP : 289.68 (-1.12%)
RF : 26.23 (+0.11%)
KNX : 56.59 (-3.89%)
MSFT : 422.94 (+1.18%)
GOOGL : 181.72 (+0.76%)
V : 309.59 (-0.24%)
KO : 63.47 (+0.17%)
META : 586.72 (+0.61%)
BA : 146.01 (-1.98%)
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

Collaboration will extend the applications of each company's platform through discovery and development of novel lipid nanoparticles using Generation Bio's proprietary stealth cell-targeted lipid nanoparticle...

MRNA : 43.46 (+1.66%)
GBIO : 2.09 (-4.13%)
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

Cash balance of $312.2M expected to fund operations into 2025...

GBIO : 2.09 (-4.13%)
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 2.09 (-4.13%)
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 2.09 (-4.13%)
Generation Bio to Present at the 2022 Jefferies Healthcare Conference

CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 2.09 (-4.13%)
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

Company continues to optimize cell-targeted lipid nanoparticle (ctLNP) delivery system for nonviral genetic medicine applications in liver, retina and...

GBIO : 2.09 (-4.13%)
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 2.09 (-4.13%)

Business Summary

Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo...

See More

Key Turning Points

3rd Resistance Point 2.54
2nd Resistance Point 2.46
1st Resistance Point 2.32
Last Price 2.09
1st Support Level 2.10
2nd Support Level 2.02
3rd Support Level 1.88

See More

52-Week High 4.65
Fibonacci 61.8% 3.28
Fibonacci 50% 2.86
Fibonacci 38.2% 2.43
Last Price 2.09
52-Week Low 1.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar